Y Intercept (Hong Kong) LTD Teva Pharmaceutical Industries LTD Transaction History

Y Intercept (Hong Kong) LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$12.78 - $17.4 $440,820 - $600,178	34,493 New	34,493 $560,000
Q2 2023 Aug 14, 2023	BUY	$7.2 - $9.47 $379,756 - $499,485	52,744 New	52,744 $397,000
Q4 2022 Feb 14, 2023	BUY	$7.95 - $9.48 $807,974 - $963,471	101,632 New	101,632 $926,000
Q2 2022 Aug 08, 2022	SELL	$7.38 - $10.4 $1.07 Million - $1.51 Million	-145,411 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$7.33 - $9.39 $1.07 Million - $1.37 Million	145,411 New	145,411 $1.37 Million
Q4 2021 Feb 14, 2022	SELL	$7.9 - $10.19 $885,992 - $1.14 Million	-112,151 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$8.38 - $10.18 $939,825 - $1.14 Million	112,151 New	112,151 $1.09 Million
Q2 2021 Aug 12, 2021	SELL	$9.9 - $11.56 $135,125 - $157,782	-13,649 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$10.34 - $12.81 $141,130 - $174,843	13,649 New	13,649 $155,000

624

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.